SCHEMBL303369

SCHEMBL303369

[CH2]Cc1cccc2c1ccc1ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 3/20 0.58
ALDH1A1 P00352 3/20 0.50
HSD17B10 Q99714 3/20 0.50
TDP1 Q9NUW8 3/20 0.50
CYP2A6 P11509 1/20 0.50
TSHR P16473 1/20 0.50
CYP1A2 P05177 4/20 0.45
CYP2C19 P33261 2/20 0.45
CYP2C9 P11712 1/20 0.45
PAX8 Q06710 1/20 0.43
HIF1A Q16665 1/20 0.43
CYP1B1 Q16678 1/20 0.43
THRB P10828 1/20 0.43
HPGD P15428 1/20 0.43
CYP2D6 P10635 1/20 0.42
ACP3 P15309 1/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
APEX1 P27695 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26212 0.87 CYP1A2 (0.58) ALDH1A1HSD17B10TDP1CYP2A6TSHR
SCHEMBL303656 0.84 HPRT1 (0.54) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL131469 0.83 HPRT1 (0.58) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL303618 0.81 HPRT1 (0.50) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL129025 0.81 HPRT1 (0.61) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL29391795 0.81 HPRT1 (0.61) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL10867996 0.80 HPRT1 (0.54) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL303467 0.80 HPRT1 (0.48) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL25393878 0.79 HPRT1 (0.58) HPRT1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL131470 0.79 HPRT1 (0.58) HPRT1ALDH1A1HSD17B10TDP1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239745-A1 METHOD FOR SYNTHESIZING BILIRUBIN Bilix Co., Ltd. (KR) 2024-07-18 US disclosed
US-12024658-B2 Water-based hybrid pressure sensitive adhesive composition and method of producing the same DOW SILICONES CORPORATION (US) 2024-07-02 US disclosed
WO-2024135665-A1 POLYIMIDE COMPOUND, NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES THAT USES SAID POLYIMIDE COMPOUND, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY ウィンゴーテクノロジー株式会社 2024-06-27 WO disclosed
CN-118176259-A Dispersion of carbon nanotubes, coating liquid composition for electrode using same, electrode, and lithium ion secondary battery 第一工业制药株式会社 2024-06-11 CN disclosed
CN-112300576-B Hot melt curable silicone composition, sealant, film, and optical semiconductor element 杜邦东丽特殊材料株式会社 2024-05-14 CN disclosed
CN-115038757-B Curable elastomer composition and method for designing transducer device 陶氏东丽株式会社 2024-04-05 CN disclosed
CN-117836290-A Synthesis method of bilirubin 株式会社毕丽斯 2024-04-05 CN disclosed
WO-2024071152-A1 ELECTRODE-LAYER-FORMING CURABLE ORGANOPOLYSILOXANE COMPOSITION, LAMINATE EQUIPPED WITH ELECTRODE LAYER, USE THEREOF, AND METHOD FOR PRODUCING SAME ダウ・東レ株式会社 2024-04-04 WO disclosed
WO-2024071151-A1 HOT MELT TYPE ORGANOPOLYSILOXANE COMPOSITION FOR FORMING ELECTRODE LAYER, MULTILAYER BODY COMPRISING ELECTRODE LAYER, USE OF SAME AND METHOD FOR PRODUCING SAME ダウ・東レ株式会社 2024-04-04 WO disclosed
WO-2024071150-A1 CURABLE ORGANOPOLYSILOXANE COMPOSITION FOR FORMING ELECTRODE LAYER, MULTILAYER BODY COMPRISING ELECTRODE LAYER, USE OF SAME AND METHOD FOR PRODUCING SAME ダウ・東レ株式会社 2024-04-04 WO disclosed
EP-0962437-B1 Linear triene and copolymer thereof MITSUI CHEMICALS INC (JP) 2002-03-27 EP disclosed
EP-1186619-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof Mitsui Chemicals, Inc. (JP) 2002-03-13 EP disclosed
EP-1152016-A1 ETHYLENE COPOLYMER RUBBER, PROCESS FOR PRODUCING THE SAME, AND USE Mitsui Chemicals, Inc. (JP) 2001-11-07 EP disclosed
US-6303727-B1 COPOLYMER OF ACYCLIC TRIENE AND ALPHA-OLEFIN; SUPERIOR IN WEATHERABILITY, HEAT RESITANCE AND FASTNESS TO OZONE, SCORCH STABILITY AND VULCANIZABILITY AT HIGH VELOCITY MITSUI CHEMICALS INC. (JP) 2001-10-16 US disclosed
US-6297333-B1 METALLOCENE TRANSITION METAL COMPOUND HAVING AN INDENYL GROUP AND A FLUORENYL GROUP AS LIGANDS, SPECIFIC SUBSTITUENT ON A SPECIFIC POSITION OF THE INDENYL GROUP GIVES HIGH MOLECULAR WEIGHT AND HIGH ACTIVITY MITSUI CHEMICALS INC (JP) 2001-10-02 US disclosed
US-6248918-B1 BIS(DIHYDROCARBYLPHOSPHINOYLALKYL)-1,1'-BINAPHTHOL) AND RARE EARTH OR GROUP 3A METAL SALTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-19 US disclosed
EP-1092730-A1 PROCESS FOR PRODUCING OLEFIN POLYMER AND OLEFIN POLYMER Mitsui Chemicals, Inc. (JP) 2001-04-18 EP disclosed
US-6004897-A TRANSITION METAL INDENE-FLUORINE COMPLEX COORDINATION CATALYST WITH ORGANOALUMINUM AND ALUMOXANE COMPOUNDS MITSUI CHEMICALS, INC. (JP) 1999-12-21 US disclosed
EP-0962437-A1 Linear triene and copolymer thereof Mitsui Chemicals, Inc. (JP) 1999-12-08 EP disclosed
EP-0754698-A2 An olefin polymerization catalyst and a process for preparing olefin polymer MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1997-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239745-A1 METHOD FOR SYNTHESIZING BILIRUBIN CYP7A1, UGT1A3, UGT1A1 HPRT1 441/4885ALDH1A1 225/4885HSD17B10 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.